SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SRDX - SurModics - Biotech IPO
SRDX 31.15+5.7%Apr 28 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Lance Bredvold8/19/2024 9:57:43 AM
   of 83
 
Still another opportunity in SRDX after I assumed we would be locked into the $43 bid from an investment firm less time value of funds. The company announced the the FTC was asking for more information about the acquisition and both firms were speedily assembling information. But there would be a delay in the actual consummation of the deal to probably Q1-25.

Last week I was able to buy more shares at $39.50 for a presumed return of $43/$39.50 of 8.9% over about 6 months. And I've written elsewhere that my preference had been that this deal never happen despite the likelihood of a sudden decline in share price if it were cancelled. I believe current management can successfully market it's slate of products profitably and develop new ones resulting in a price higher than $43 within 5 years.

This morning the quoted price was $40.09 and that would reward me 7.25% to $43 in around 6 months. Still worth doing though I'm over my budgeted purchases for this month already. In fact, I prefer moving the gain from H2-24 to Q1-25 since I've harvested so many unusual gains this year from nearly all my holdings and next year may have none--at least I don't know that there will be many. I think I'll offer $39.75 for another batch and if it comes I'll be content.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext